Reduced fluoroquinolone susceptibility in Salmonella enterica isolates from travelers, Finland.
We tested the fluoroquinolone susceptibility of 499 Salmonella enterica isolates collected from travelers returning to Finland during 2003-2007. Among isolates from travelers to Thailand and Malaysia, reduced fluoroquinolone susceptibility decreased from 65% to 22% (p = 0.002). All isolates showing nonclassical quinolone resistance were from travelers to these 2 countries.
Lindgren
Marianne M
MM
National Institute of Health and Welfare, Turku, Finland. marianne.lindgren@utu.fi
Kotilainen
Pirkko
P
Huovinen
Pentti
P
Hurme
Saija
S
Lukinmaa
Susanna
S
Webber
Mark A
MA
Piddock
Laura J V
LJ
Siitonen
Anja
A
Hakanen
Antti J
AJ
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D000890:Anti-Infective Agents / Q000494:pharmacology; D002939:Ciprofloxacin / Q000494:pharmacology; D024881:Drug Resistance, Bacterial; D005387:Finland; D024841:Fluoroquinolones / Q000494:pharmacology*; D006801:Humans; D008826:Microbial Sensitivity Tests; D009268:Nalidixic Acid / Q000494:pharmacology; D012480:Salmonella Infections / Q000382:microbiology; D019779:Salmonella enterica / Q000145:classification / Q000187:drug effects* / Q000302:isolation & purification; D012703:Serotyping; D014195:Travel
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D009268:Nalidixic Acid; D002939:Ciprofloxacin